BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19566726)

  • 1. In vivo preclinical anticoagulation regimens after implantation of ventricular assist devices.
    Saeed D; Fukamachi K
    Artif Organs; 2009 Jul; 33(7):491-503. PubMed ID: 19566726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of adverse events in preclinical ventricular assist device experiments.
    Litwak KN; Unger LS; Fukamachi K; Saeed D
    ASAIO J; 2008; 54(4):347-50. PubMed ID: 18645350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Currently available ventricular-assist devices: capabilities, limitations and future perspectives.
    Ohuchi K; Takatani S
    Expert Rev Med Devices; 2006 Mar; 3(2):195-205. PubMed ID: 16515386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemostatic history of a 15-month-old child implanted with a Berlin heart left ventricular assist device.
    Steenwyk BL; Kirklin JK; Gurley WQ; Nielsen VG
    Anesth Analg; 2007 Mar; 104(3):538-40. PubMed ID: 17312204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
    Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
    Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
    Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
    ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy due to thrombus formation associated with left ventricular assist devices.
    Rothenburger M; Schmid C; Huelksen G; Loeher A; Scheld HH
    J Heart Lung Transplant; 2005 Dec; 24(12):2305. PubMed ID: 16364888
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation and bleeding in patients with ventricular assist devices: walking the tightrope.
    Kurien S; Hughes KA
    AACN Adv Crit Care; 2012; 23(1):91-8. PubMed ID: 22290095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical readiness testing of the Arrow International CorAide left ventricular assist system.
    Doi K; Golding LA; Massiello AL; Kopcak MW; Gerhart RL; Schenk S; Inoue M; Ootaki Y; Fukamachi K
    Ann Thorac Surg; 2004 Jun; 77(6):2103-10. PubMed ID: 15172276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
    Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term in vivo studies of surface thrombosis in a left ventricular assist system.
    Yamanaka H; Rosenberg G; Weiss WJ; Snyder AJ; Zapanta CM; Siedlecki CA
    ASAIO J; 2006; 52(3):257-65. PubMed ID: 16760713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis in Pediatric Extracorporeal Life Support: Overview and Challenges.
    Martin AA; Bhat R; Chitlur M
    Pediatr Clin North Am; 2022 Jun; 69(3):441-464. PubMed ID: 35667756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?
    Warkentin TE; Greinacher A; Koster A
    Ann Thorac Surg; 2009 May; 87(5):1633-40. PubMed ID: 19379937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular assist devices in children: current achievements and future perspectives.
    Potapov EV; Stiller B; Hetzer R
    Pediatr Transplant; 2007 May; 11(3):241-55. PubMed ID: 17430478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aortic valve incompetence on the hemodynamics of a continuous flow ventricular assist device in a mock circulation.
    Zamarripa Garcia MA; Enriquez LA; Dembitsky W; May-Newman K
    ASAIO J; 2008; 54(3):237-44. PubMed ID: 18496272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding and Thrombotic Events in Patients Undergoing Mechanical Circulatory Support: A Review of Literature.
    Petricevic M; Milicic D; Boban M; Mihaljevic MZ; Baricevic Z; Kolic K; Dolic K; Konosic L; Kopjar T; Biocina B
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):636-46. PubMed ID: 25742553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postcardiotomy cardiogenic shock: the role of ventricular assist devices.
    Hagan K; Casanova-Ghosh E
    Crit Care Nurs Clin North Am; 2007 Dec; 19(4):427-43, vi-vii. PubMed ID: 18022528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent.
    Studer MA; Kennedy CE; Dreyer WJ; Price JF; Moffett BS; Teitel ER; Carberry KE; Morales DL; McKenzie ED; Chang AC
    J Heart Lung Transplant; 2006 Jul; 25(7):857-61. PubMed ID: 16818131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.